Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,676–5,700 of 7,816 matching trials · page 228 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease NCT04021888 Exercise Runs in: Turkey (Türkiye) · 1 site |
NA other |
UNKNOWN | 60 | Dokuz Eylul University OTHER |
2019-07-17 |
|
Reducing Depressive Symptomatology With a Smartphone App NCT03060200 Self-administered online CBT plus therapist check in; Sham self-adm... Runs in: Romania · 1 site |
NA other |
COMPLETED | 158 | Babes-Bolyai University OTHER |
2019-07-16 |
|
Video Games to Track Cognitive Health NCT03608722 SLUMS; MMSE; MoCA; BrainCheck |
NA other |
UNKNOWN | 2,500 | BrainCheck, Inc. OTHER |
2019-07-16 |
|
Development and Application of Portable Multisensory Stimulation Device NCT04005313 vibroacoustic device Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 60 | Buddhist Tzu Chi General Hospital OTHER |
2019-07-16 |
|
Mobile Tablet Education to Advance Caregiver Health NCT03417219 Education and Skill Building Rehabilitation-mobile (ESBR-m); Usual ... Runs in: United States · 1 site |
NA other |
COMPLETED | 16 | VA Office of Research and Development OTHER_GOV |
2019-07-15 |
|
Evolving Methods to Combine Cognitive and Physical Training for Individuals With Mild Cognitive Impairment NCT02512627 Cognitive training; Physical exercise Runs in: Taiwan · 9 sites |
NA other |
COMPLETED | 55 | Chang Gung Memorial Hospital OTHER |
2019-07-12 |
|
18F-Flutemetamol and Plaque Vulnerability NCT03291093 18F-Flutemetamol PET/MRI Runs in: Netherlands · 1 site |
PHASE2|PHASE3 other |
UNKNOWN | 25 | Maastricht University Medical Center OTHER |
2019-07-11 |
|
Preventing Language Decline in Dementia NCT02541097 Language therapy Runs in: Canada · 1 site |
NA other |
COMPLETED | 20 | Baycrest OTHER |
2019-07-09 |
|
Modulation of Cognition and Brain Connectivity by Noninvasive Brain Stimulation in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease NCT04012346 Transcranial magnetic stimulation Runs in: Czechia · 1 site |
NA other |
UNKNOWN | 20 | Masaryk University OTHER |
2019-07-09 |
|
Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD NCT02221622 Allopregnanolone injection (intravenous solution); Placebo injectio... Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 24 | University of Southern California OTHER |
2019-07-05 |
|
Telomerase Activator and Retinal Amyloid NCT02530255 cycloastragenol; placebo (for cycloastragenol) Runs in: United States · 1 site |
NA other |
COMPLETED | 48 | Chippewa Valley Eye Clinic OTHER |
2019-07-05 |
|
MORbidity PRevalence Estimate In StrokE NCT03605381 Runs in: United Kingdom · 3 sites |
NA other |
UNKNOWN | 500 | Aneurin Bevan University Health Board OTHER |
2019-07-05 |
|
Multisensory Stimulation in Dementia. NCT04008342 Multisensory intervention Runs in: Brazil · 1 site |
NA other |
COMPLETED | 60 | Federal University of Minas Gerais OTHER |
2019-07-05 |
|
AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease NCT02284906 Pioglitazone; Placebo Runs in: Australia; Switzerland; United Kingdom; United States · 43 sites |
PHASE3 other |
TERMINATED | 40 | Takeda INDUSTRY |
2019-07-02 |
|
Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) NCT04004702 Levetiracetam Runs in: United States · 1 site |
PHASE2 other |
UNKNOWN | 65 | Walter Reed National Military Medical Center OTHER_GOV |
2019-07-02 |
|
Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study NCT01684293 Occupational therapy-based cognitive rehabilitation; Psychoeducation/games Runs in: United States · 1 site |
NA other |
COMPLETED | 50 | University of California, San Francisco OTHER |
2019-07-01 |
|
Accompanying ALZHEIMER CAREGIVER NCT03994237 semi-structured interview Runs in: France · 1 site |
NA other |
COMPLETED | 45 | University Hospital, Bordeaux OTHER |
2019-07-01 |
|
Caring for the Caregiver Network NCT03049501 Caregiving condition; Nutrition condition Runs in: United States · 1 site |
NA other |
COMPLETED | 244 | University of Miami OTHER |
2019-06-25 |
|
Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease NCT03319810 Octagam 10% Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 5 | Sutter Health OTHER |
2019-06-25 |
|
Upper Limb Reeducation Across Life Span NCT03997591 Ready2E.A.T. PROGRAM Runs in: Portugal · 1 site |
NA other |
COMPLETED | 15 | Instituto Politécnico de Leiria OTHER |
2019-06-25 |
|
A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD) NCT02423122 VX-745 Runs in: Netherlands · 1 site |
PHASE2 other |
COMPLETED | 16 | EIP Pharma Inc INDUSTRY |
2019-06-14 |
|
Non-pharmacological Interventions on Cognitive Functions in Older People With Mild Cognitive Impairment NCT03545152 Exercise; Cognitive training; New life-style |
NA other |
COMPLETED | 192 | Tzu-Ting Huang OTHER |
2019-06-14 |
|
Alzheimer Biomarkers on CSF of Elderly Patients Undergoing Surgery NCT03977025 Lumbar punction Runs in: Chile · 1 site |
NA other |
UNKNOWN | 30 | University of Chile OTHER |
2019-06-13 |
|
A Study to Evaluate the Efficacy and Safety of Brain Polypeptide Solution in Mild Alzheimer's Disease NCT03978338 brain polypeptide solution; same package of placebo |
NA other |
UNKNOWN | 200 | Peking Union Medical College Hospital OTHER |
2019-06-11 |
|
Evaluating Liraglutide in Alzheimer's Disease NCT01843075 Liraglutide; Placebo Runs in: United Kingdom · 1 site |
PHASE2 GLP-1 |
UNKNOWN | 204 | Imperial College London OTHER |
2019-06-10 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial